AC
Aisling Capital Management LP
NEW YORK NY · SEC CIK 0001766721
$471.62M2026Q2 reported value
14Positions
99.0%Top 10 weight · largest 72.5%
1 / 0New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
VTV THERAPEUTICS New+$1.88M
2026Q2 top sells estimated at quarter-end value
BBIO Reduced-$37.24M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| BBIO | BRIDGEBIO PHARMA INC | $341.83M | 72.48% | 4,589,611 | -500,000 | -9.8% | -$37.24M | Reduced |
| GLUE | MONTE ROSA THERAPEUTICS INC | $37.65M | 7.98% | 1,555,664 | 0 | 0.0% | — | Unchanged |
| SNDX | SYNDAX PHARMACEUTICALS INC | $28.79M | 6.10% | 1,316,806 | 0 | 0.0% | — | Unchanged |
| CMPS | COMPASS PATHWAYS PLC | $20.27M | 4.30% | 1,432,336 | 0 | 0.0% | — | Unchanged |
| BCAX | BICARA THERAPEUTICS INC | $16.89M | 3.58% | 568,919 | 0 | 0.0% | — | Unchanged |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $7.76M | 1.64% | 1,018,018 | 0 | 0.0% | — | Unchanged |
| SRRK | SCHOLAR ROCK HLDG CORP | $4.24M | 0.90% | 77,031 | 0 | 0.0% | — | Unchanged |
| URGN | UROGEN PHARMA LTD | $3.97M | 0.84% | 108,000 | 0 | 0.0% | — | Unchanged |
| — | BIOMEA FUSION INC | $3.01M | 0.64% | 2,048,757 | 0 | 0.0% | — | Unchanged |
| ACRS | ACLARIS THERAPEUTICS INC | $2.30M | 0.49% | 434,455 | 0 | 0.0% | — | Unchanged |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | $2.15M | 0.46% | 325,000 | 0 | 0.0% | — | Unchanged |
| — | VTV THERAPEUTICS INC | $1.88M | 0.40% | 50,000 | 50,000 | — | $1.88M | New |
| — | MARKER THERAPEUTICS INC | $478,293 | 0.10% | 325,370 | 0 | 0.0% | — | Unchanged |
| OKUR | ONKURE THERAPEUTICS INC | $404,048 | 0.09% | 88,607 | 0 | 0.0% | — | Unchanged |